Off-Target Effects of Recombinant Zoster Vaccine: Clinical Benefits, AS01B Adjuvant Immunobiology, and Observational Evidence.

Research paper from Europe PMC. Evidence status: source reported.

Published

2026-10-03

Source reference

MED:42931408

DOI

10.3390/vaccines14100879

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

Tang J, Balaji S, Oon HH. · Vaccines (Basel) · review-article; review; journal article · Found via: UK Biobank

Source: https://europepmc.org/article/MED/42931408. Captured 2026-10-31.

Limitations: Discovered through a Europe PMC keyword search for UK Biobank. A mention is not a verified link to an access authorisation, project, dataset or clinical outcome. Preprints may not be peer reviewed.